Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Journal articles
  4. Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland
 
research article

Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland

Stringhini, Silvia
•
Zaballa, Maria-Eugenia
•
Pullen, Nick
Show more
June 8, 2021
Nature Communications

Limited data exist on SARS-CoV-2 infection rates across sectors and occupations, hindering our ability to make rational policy, including vaccination prioritization, to protect workers and limit SARS-CoV-2 spread. Here, we present results from our SEROCoV-WORK+study, a serosurvey of workers recruited after the first wave of the COVID-19 pandemic in Geneva, Switzerland. We tested workers (May 18-September 18, 2020) from 16 sectors and 32 occupations for anti-SARS-CoV-2 IgG antibodies. Of 10,513 participants, 1026 (9.8%) tested positive. The seropositivity rate ranged from 4.2% in the media sector to 14.3% in the nursing home sector. We found considerable within-sector variability: nursing home (0%-31.4%), homecare (3.9%-12.6%), healthcare (0%-23.5%), public administration (2.6%-24.6%), and public security (0%-16.7%). Seropositivity rates also varied across occupations, from 15.0% among kitchen staff and 14.4% among nurses, to 5.4% among domestic care workers and 2.8% among journalists. Our findings show that seropositivity rates varied widely across sectors, between facilities within sectors, and across occupations, reflecting a higher exposure in certain sectors and occupations. Many job sectors classified as 'essential' have continued operating with limited restrictions during the COVID-19 pandemic, potentially placing workers at higher risk of infection. Here, the authors show that seropositivity rates in workers vary widely across and between job sectors in Geneva, Switzerland.

  • Files
  • Details
  • Metrics
Type
research article
DOI
10.1038/s41467-021-23796-4
Web of Science ID

WOS:000664856900013

Author(s)
Stringhini, Silvia
Zaballa, Maria-Eugenia
Pullen, Nick
de Mestral, Carlos
Perez-Saez, Javier
Dumont, Roxane
Picazio, Attilio
Pennacchio, Francesco
Dibner, Yaron
Yerly, Sabine
Show more
Date Issued

2021-06-08

Publisher

Nature Research

Published in
Nature Communications
Volume

12

Issue

1

Article Number

3455

Subjects

Multidisciplinary Sciences

•

Science & Technology - Other Topics

•

united-states

•

sars-cov-2

•

seroprevalence

•

covid-19

Editorial or Peer reviewed

REVIEWED

Written at

EPFL

EPFL units
LVG  
Available on Infoscience
July 17, 2021
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/180117
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés